Hypothalamic CaMKK2 Contributes to the Regulation of Energy Balance

Cell Metabolism

Volumn 7, Issue 5, 2008, Pages 377-388

  Anderson, Kristin A ^a   Ribar, Thomas J ^a   Lin, Fumin ^a   Noeldner, Pamela K ^a   Green, Michelle F ^a   Muehlbauer, Michael J ^a   Witters, Lee A ^b   Kemp, Bruce E ^c   Means, Anthony R ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

HUMDISEASE; MOLNEURO

Indexed keywords

AGOUTI RELATED PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ALPHA; CYCLIC AMP DEPENDENT PROTEIN KINASE BETA; GLUCOSE; INSULIN; MESSENGER RNA; NUCLEAR FACTOR Y; PROTEIN KINASE (CALCIUM,CALMODULIN) II; PROTEIN KINASE KINASE (CALCIUM,CALMODULIN) II;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APPETITE; ARTICLE; CONTROLLED STUDY; ENERGY BALANCE; ENZYME ACTIVITY; GLUCOSE INTOLERANCE; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOTHALAMUS; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; INSULIN RESISTANCE; LIPID DIET; METABOLIC REGULATION; MOUSE; MUTAGENESIS; NONHUMAN; OBESITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WEIGHT REDUCTION; WILD TYPE;

ACETYL-COA CARBOXYLASE; AGOUTI-RELATED PROTEIN; ANIMALS; APPETITE REGULATION; BENZIMIDAZOLES; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE; CELLS, CULTURED; DIET, ATHEROGENIC; ENERGY METABOLISM; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HYPOTHALAMUS; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; INSULIN; INSULIN RESISTANCE; INTEGRASES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NAPHTHALIMIDES; NEUROPEPTIDE Y; PROTEIN KINASES; RNA, MESSENGER; TRANSFECTION; WEIGHT LOSS;

MUS;

EID: 42649105456     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2008.02.011     Document Type: Article

References (53)

1. Anderson K.A., Means R.L., Huang Q.H., Kemp B.E., Goldstein E.G., Selbert M.A., Edelman A.M., Fremeau R.T., and Means A.R. Components of a calmodulin-dependent protein kinase cascade. Molecular cloning, functional characterization and cellular localization of Ca2+/calmodulin-dependent protein kinase kinase beta. J. Biol. Chem. 273 (1998) 31880-31889
2. Andersson U., Filipsson K., Abbott C.R., Woods A., Smith K., Bloom S.R., Carling D., and Small C.J. AMP-activated protein kinase plays a role in the control of food intake. J. Biol. Chem. 279 (2004) 12005-12008
3. Bagnasco M., Kalra P.S., and Kalra S.P. Ghrelin and leptin pulse discharge in fed and fasted rats. Endocrinology 143 (2002) 726-729
4. Banks W.A. Is obesity a disease of the blood-brain barrier? Physiological, pathological, and evolutionary considerations. Curr. Pharm. Des. 9 (2003) 801-809
5. Broberger C., and Hokfelt T. Hypothalamic and vagal neuropeptide circuitries regulating food intake. Physiol. Behav. 74 (2001) 669-682
6. Chen Z.P., Stephens T.J., Murthy S., Canny B.J., Hargreaves M., Witters L.A., Kemp B.E., and McConell G.K. Effect of exercise intensity on skeletal muscle AMPK signaling in humans. Diabetes 52 (2003) 2205-2212
7. Clark J.T., Kalra P.S., Crowley W.R., and Kalra S.P. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115 (1984) 427-429
8. Crute B.E., Seefeld K., Gamble J., Kemp B.E., and Witters L.A. Functional domains of the alpha1 catalytic subunit of the AMP-activated protein kinase. J. Biol. Chem. 273 (1998) 35347-35354
9. Cummings D.E., Weigle D.S., Frayo R.S., Breen P.A., Ma M.K., Dellinger E.P., and Purnell J.Q. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N. Engl. J. Med. 346 (2002) 1623-1630
10. Cummings D.E., Foster-Schubert K.E., and Overduin J. Ghrelin and energy balance: focus on current controversies. Curr. Drug Targets 6 (2005) 153-169
11. Dyck J.R., Gao G., Widmer J., Stapleton D., Fernandez C.S., Kemp B.E., and Witters L.A. Regulation of 5′-AMP-activated protein kinase activity by the noncatalytic beta and gamma subunits. J. Biol. Chem. 271 (1996) 17798-17803
12. Elmquist J.K., Coppari R., Balthasar N., Ichinose M., and Lowell B.B. Identifying hypothalamic pathways controlling food intake, body weight, and glucose homeostasis. J. Comp. Neurol. 493 (2005) 63-71
13. Erickson J.C., Clegg K.E., and Palmiter R.D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381 (1996) 415-421
14. Esler W.P., Rudolph J., Claus T.H., Tang W., Barucci N., Brown S.E., Bullock W., Daly M., Decarr L., Li Y., et al. Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss. Endocrinology 148 (2007) 5175-5185
15. Flier J.S. Obesity wars: molecular progress confronts an expanding epidemic. Cell 116 (2004) 337-350
16. Friedman J.M., and Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 395 (1998) 763-770
17. Gainetdinov R.R., Bohn L.M., Walker J.K., Laporte S.A., Macrae A.D., Caron M.G., Lefkowitz R.J., and Premont R.T. Muscarinic supersensitivity and impaired receptor desensitization in G protein-coupled receptor kinase 5-deficient mice. Neuron 24 (1999) 1029-1036
18. Golay A., and Ybarra J. Link between obesity and type 2 diabetes. Best Pract. Res. Clin. Endocrinol. Metab. 19 (2005) 649-663
19. Gropp E., Shanabrough M., Borok E., Xu A.W., Janoschek R., Buch T., Plum L., Balthasar N., Hampel B., Waisman A., et al. Agouti-related peptide-expressing neurons are mandatory for feeding. Nat. Neurosci. 8 (2005) 1289-1291
20. Hardie D.G., Scott J.W., Pan D.A., and Hudson E.R. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett. 546 (2003) 113-120
21. Hawley S.A., Pan D.A., Mustard K.J., Ross L., Bain J., Edelman A.M., Frenguelli B.G., and Hardie D.G. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2 (2005) 9-19
22. Heymsfield S.B., Greenberg A.S., Fujioka K., Dixon R.M., Kushner R., Hunt T., Lubina J.A., Patane J., Self B., Hunt P., and McCamish M. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 282 (1999) 1568-1575
23. Holst B., Brandt E., Bach A., Heding A., and Schwartz T.W. Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signaling. Mol. Endocrinol. 19 (2005) 2400-2411
24. Hu Z., Dai Y., Prentki M., Chohnan S., and Lane M.D. A role for hypothalamic malonyl-CoA in the control of food intake. J. Biol. Chem. 280 (2005) 39681-39683
25. Hurley R.L., Anderson K.A., Franzone J.M., Kemp B.E., Means A.R., and Witters L.A. The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J. Biol. Chem. 280 (2005) 29060-29066
26. Hurley R.L., Barre L.K., Wood S.D., Anderson K.A., Kemp B.E., Means A.R., and Witters L.A. Regulation of AMP-activated protein kinase by multisite phosphorylation in response to agents that elevate cellular cAMP. J. Biol. Chem. 281 (2006) 36662-36672
27. Kalra S.P., and Kalra P.S. NPY and cohorts in regulating appetite, obesity and metabolic syndrome: beneficial effects of gene therapy. Neuropeptides 38 (2004) 201-211
28. Kohno D., Gao H.Z., Muroya S., Kikuyama S., and Yada T. Ghrelin directly interacts with neuropeptide-Y-containing neurons in the rat arcuate nucleus: Ca2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin. Diabetes 52 (2003) 948-956
29. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
30. Kola B., Hubina E., Tucci S.A., Kirkham T.C., Garcia E.A., Mitchell S.E., Williams L.M., Hawley S.A., Hardie D.G., Grossman A.B., and Korbonits M. Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. J. Biol. Chem. 280 (2005) 25196-25201
31. Kushi A., Sasai H., Koizumi H., Takeda N., Yokoyama M., and Nakamura M. Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice. Proc. Natl. Acad. Sci. USA 95 (1998) 15659-15664
32. Lambert P.D., Anderson K.D., Sleeman M.W., Wong V., Tan J., Hijarunguru A., Corcoran T.L., Murray J.D., Thabet K.E., Yancopoulos G.D., and Wiegand S.J. Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity. Proc. Natl. Acad. Sci. USA 98 (2001) 4652-4657
33. Luquet S., Perez F.A., Hnasko T.S., and Palmiter R.D. NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science 310 (2005) 683-685
34. Mashiko S., Ishihara A., Iwaasa H., Sano H., Oda Z., Ito J., Yumoto M., Okawa M., Suzuki J., Fukuroda T., et al. Characterization of neuropeptide Y (NPY) Y5 receptor-mediated obesity in mice: chronic intracerebroventricular infusion of D-Trp(34)NPY. Endocrinology 144 (2003) 1793-1801
35. Minokoshi Y., Alquier T., Furukawa N., Kim Y.B., Lee A., Xue B., Mu J., Foufelle F., Ferre P., Birnbaum M.J., et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428 (2004) 569-574
36. Mori H., Hanada R., Hanada T., Aki D., Mashima R., Nishinakamura H., Torisu T., Chien K.R., Yasukawa H., and Yoshimura A. Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat. Med. 10 (2004) 739-743
37. Morton G.J., Cummings D.E., Baskin D.G., Barsh G.S., and Schwartz M.W. Central nervous system control of food intake and body weight. Nature 443 (2006) 289-295
38. Munzberg H., and Myers Jr. M.G. Molecular and anatomical determinants of central leptin resistance. Nat. Neurosci. 8 (2005) 566-570
39. Neumann D., Woods A., Carling D., Wallimann T., and Schlattner U. Mammalian AMP-activated protein kinase: functional, heterotrimeric complexes by co-expression of subunits in Escherichia coli. Protein Expr. Purif. 30 (2003) 230-237
40. Pedrazzini T., Seydoux J., Kunstner P., Aubert J.F., Grouzmann E., Beermann F., and Brunner H.R. Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor. Nat. Med. 4 (1998) 722-726
41. Petro A.E., Cotter J., Cooper D.A., Peters J.C., Surwit S.J., and Surwit R.S. Fat, carbohydrate, and calories in the development of diabetes and obesity in the C57BL/6J mouse. Metabolism 53 (2004) 454-457
42. Sakamoto K., McCarthy A., Smith D., Green K.A., Grahame Hardie D., Ashworth A., and Alessi D.R. Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. EMBO J. 24 (2005) 1810-1820
43. Segal-Lieberman G., Trombly D.J., Juthani V., Wang X., and Maratos-Flier E. NPY ablation in C57BL/6 mice leads to mild obesity and to an impaired refeeding response to fasting. Am. J. Physiol. Endocrinol. Metab. 284 (2003) E1131-E1139
44. Shaw R.J., Kosmatka M., Bardeesy N., Hurley R.L., Witters L.A., DePinho R.A., and Cantley L.C. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl. Acad. Sci. USA 101 (2004) 3329-3335
45. Shaw R.J., Lamia K.A., Vasquez D., Koo S.H., Bardeesy N., Depinho R.A., Montminy M., and Cantley L.C. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310 (2005) 1642-1646
46. Steinberg G.R., Watt M.J., Fam B.C., Proietto J., Andrikopoulos S., Allen A.M., Febbraio M.A., and Kemp B.E. Ciliary neurotrophic factor suppresses hypothalamic AMP-kinase signaling in leptin-resistant obese mice. Endocrinology 147 (2006) 3906-3914
47. Sun Y., Wang P., Zheng H., and Smith R.G. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc. Natl. Acad. Sci. USA 101 (2004) 4679-4684
48. Surwit R.S., Kuhn C.M., Cochrane C., McCubbin J.A., and Feinglos M.N. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37 (1988) 1163-1167
49. Tokumitsu H., Takahashi N., Eto K., Yano S., Soderling T.R., and Muramatsu M. Substrate recognition by Ca2+/Calmodulin-dependent protein kinase kinase. Role of the arg-pro-rich insert domain. J. Biol. Chem. 274 (1999) 15803-15810
50. Tokumitsu H., Inuzuka H., Ishikawa Y., Ikeda M., Saji I., and Kobayashi R. STO-609, a specific inhibitor of the Ca(2+)/calmodulin-dependent protein kinase kinase. J. Biol. Chem. 277 (2002) 15813-15818
51. Witters L.A., Kemp B.E., and Means A.R. Chutes and Ladders: the search for protein kinases that act on AMPK. Trends Biochem. Sci. 31 (2006) 13-16
52. Woods A., Dickerson K., Heath R., Hong S.P., Momcilovic M., Johnstone S.R., Carlson M., and Carling D. Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2 (2005) 21-33
53. Zamboni M., Mazzali G., Zoico E., Harris T.B., Meigs J.B., Di Francesco V., Fantin F., Bissoli L., and Bosello O. Health consequences of obesity in the elderly: a review of four unresolved questions. Int. J. Obes. (Lond.) 29 (2005) 1011-1029